Yüklüyor......
Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset
Data from randomized clinical trials have supported the safety and efficacy of intravenous tissue-type plasminogen activator (IV tPA) for acute ischemic stroke when administered within 3 hours of symptom onset, and regulatory approvals for this indication have been in place for almost 20 years. Howe...
Kaydedildi:
| Yayımlandı: | Neurohospitalist |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530422/ https://ncbi.nlm.nih.gov/pubmed/26288668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1941874415583116 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|